Balboa Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-402
| Closed | -$200K | – | 406 |
|
|
2025
Q1 | $200K | Buy |
402
+1
| +0.2% | +$498 | 0.05% | 270 |
|
|
2024
Q4 | $209K | Sell |
401
-482
| -55% | -$251K | 0.05% | 274 |
|
|
2024
Q3 | $546K | Buy |
883
+330
| +60% | +$204K | 0.14% | 130 |
|
|
2024
Q2 | $306K | Buy |
553
+43
| +8% | +$23.8K | 0.08% | 188 |
|
|
2024
Q1 | $297K | Sell |
510
-12
| -2% | -$6.98K | 0.09% | 167 |
|
|
2023
Q4 | $277K | Buy |
522
+10
| +2% | +$5.31K | 0.09% | 171 |
|
|
2023
Q3 | $259K | Buy |
512
+18
| +4% | +$9.11K | 0.1% | 178 |
|
|
2023
Q2 | $258K | Sell |
494
-260
| -34% | -$136K | 0.09% | 185 |
|
|
2023
Q1 | $435K | Buy |
754
+206
| +38% | +$119K | 0.16% | 125 |
|
|
2022
Q4 | $302K | Sell |
548
-54
| -9% | -$29.7K | 0.14% | 152 |
|
|
2022
Q3 | $305K | Buy |
+602
| New | +$305K | 0.13% | 135 |
|